Addex Therapeutics Ltd. (ADXN)
7.76
+0.08
(+1.04%)
USD |
NASDAQ |
Dec 30, 16:00
7.76
0.00 (0.00%)
After-Hours: 18:04
Addex Therapeutics EPS Diluted (Quarterly): -2.099 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 1.092 |
| AC Immune SA | -0.1964 |
| CRISPR Therapeutics AG | -1.166 |
| NewCelX Ltd. | -- |
| Molecular Partners AG | -0.3955 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.971M |
| Revenue (Quarterly) | 0.062M |
| Total Expenses (Quarterly) | 2.033M |
| Enterprise Value | 6.759M |
| Profit Margin (Quarterly) | -3.18K% |
| Earnings Yield | -108.7% |
| Normalized Earnings Yield | -108.71 |